Кристи Фанк - Грудь. Руководство пользователя [litres]

A. Lucci et al., “Surgical Complications Associated with Sentinel Lymph Node Dissection (SLND) Plus Axillary Lymph Node Dissection Compared with SLND Alone in the American College of Surgeons Oncology Group Trial,” Journal of Clinical Oncology 25 (2007): 3657.

L. G. Wilke et al., “Surgical Complications Associated with Sentinel Lymph Node Biopsy: Results from a Prospective International Cooperative Group Trial,” Annals of Surgical Oncology 13, no. 4 (2006): 491–500; R. E. Mansel et al., “Randomized Multicenter Trial of Sentinel Node Biopsy versus Standard Axillary Treatment in Operable Breast Cancer: The ALMANAC Trial,” Journal of the National Cancer Institute 98, no. 9 (May 2006): 599–609.

A. E. Giuliano et al., “Axillary Dissection vs No Axillary Dissection in Women with Invasive Breast Cancer and Sentinel Node Metastasis: A Randomized Clinical Trial. Journal of the American Medical Association 305 (2011): 569–575.

T. W. F. Yen et al., “Predictors of Invasive Breast Cancer in Patients with an Initial Diagnosis of Ductal Carcinoma In Situ: A Guide to Selective Use of Sentinel Lymph Node Biopsy in Management of Ductal Carcinoma In Situ,” Journal of the American College of Surgeons 200, no. 4 (2005): 516–526.

I. A. Czyszczon, L. Roland, and S. Sahoo, “Routine Prophylactic Sentinel Lymph Node Biopsy Is Not Indicated in Women Undergoing Prophylactic Mastectomy,” Journal of Surgical Oncology 105, no. 7 (June 2012): 650–654; S. M. Nasser, S. G. Smith, and A. B. Chagpar, “The Role of Sentinel Node Biopsy in Women Undergoing Prophylactic Mastectomy,” Journal of Surgical Research 164, no. 2 (2010): 188–192.

L. De La Cruz et al., “Overall Survival, Disease-Free Survival, Local Recurrence, and Nipple-Areolar Recurrence in the Setting of Nipple-Sparing Mastectomy: A Meta-analysis and Systematic Review,” Annals of Surgical Oncology 22, no. 10 (2015): 3241–3249.

K. Jonsson et al., “Tissue Oxygen Measurements in Delayed Skin Flaps: A Reconsideration of the Mechanisms of the Delay Phenomena,” Plastic and Reconstructive Surgery 82 (1988): 328–335.

B. Palmieri et al., “Delayed Nipple‐Sparing Modified Subcutaneous Mastectomy: Rationale and Technique,” The Breast Journal 11, no. 3 (2005): 173–178.

S. Ghali et al., “Vascular Delay Revisited,” Plastic and Reconstructive Surgery 119 (2007): 1735–1744.

J. A. Jensen et al., “Surgical Delay of the Nipple – Areolar Complex: A Powerful Technique to Maximize Nipple Viability Following Nipple-Sparing Mastectomy,” Annals of Surgical Oncology 19, no. 10 (2012): 3171–3176.

S. L. Spear et al., “Breast Reconstruction Using a Staged Nipple-Sparing Mastectomy Following Mastopexy or Reduction,” Plastic and Reconstructive Surgery 129, no. 3 (2012): 572–581.

R. M. Leach, P. J. Rees, and P. Wilmshurst, “ABC of Oxygen: Hyperbaric Oxygen Therapy,” British Medical Journal 317, no. 7166 (1998): 1140.

C. R. Albornoz et al., “A Paradigm Shift in U. S. Breast Reconstruction: Increasing Implant Rates,” Plastic and Reconstructive Surgery 131, no. 1 (2013): 15–23.

A. K. Alderman et al., “Racial and Ethnic Disparities in the Use of Postmastectomy Breast Reconstruction: Results from a Population-Based Study,” Journal of Clinical Oncology 27, no. 32 (2009): 5325–5330; L. Kruper et al., “Disparities in Reconstruction Rates after Mastectomy: Patterns of Care and Factors Associated with the Use of Breast Reconstruction in Southern California,” Annals of Surgical Oncology 18, no. 8 (2011): 2158–2165.

M. Morrow et al., “Access to Breast Reconstruction after Mastectomy and Patient Perspectives on Reconstruction Decision Making,” JAMA Surgery 149, no. 10 (2014): 1015–1021.

R. J. Bleicher et al., “Time to Surgery and Breast Cancer Survival in the United States,” JAMA Oncology 2, no. 3 (2016): 330–339.

D. J. MacKay and A. L. Miller, “Nutritional Support for Wound Healing,” Alternative Medicine Review 8, no. 4 (2003): 359–378.

P. H. Huang et al., “Emodin and Aloe-emodin Suppress Breast Cancer Cell Proliferation through ERκInhibition,” Evidence-Based Complementary and Alternative Medicine (2013); L. Zhang and I. R. Tizard, “Activation of a Mouse Macrophage Cell Line by Acemannan: The Major Carbohydrate Fraction from Aloe Vera Gel,” Immunopharmacology 35, no. 2 (1996): 119–128.

B. Sweeney et al., “Evidence-Based Systematic Review of Dandelion (Taraxacum Officinale) by Natural Standard Research Collaboration,” Journal of Herbal Pharmacotherapy 5, no. 1 (2005): 79–93.

P. M. Kidd, “Phosphatidyl Choline as an Aid to Liver Function,” Nutrition Science News 1 (1996): 54.

H. Greenlee et al., “Clinical Applications of Silybum Marianum in Oncology,” Integrative Cancer Therapies 6, no. 2 (2007): 158–165.

D. J. MacKay and A. L. Miller, “Nutritional Support for Wound Healing,” Alternative Medicine Review 8, no. 4 (2003): 359–378.

N. Chaiyakunapruk et al., “The Efficacy of Ginger for the Prevention of Postoperative Nausea and Vomiting: A Meta-analysis,” American Journal of Obstetrics and Gynecology 194 (2006): 95–99.

S. Prapaitrakool, A. Itharat, and L. Morinda, “Citrifolia for Prevention of Postoperative Nausea and Vomiting,” Journal of the Medical Association of Thailand 93, no. 7 (2010): S204–209.

J. Webster and S. Osborne, “Preoperative Bathing or Showering with Skin Antiseptics to Prevent Surgical Site Infection,” Cochrane Database of Systematic Reviews 2 (2007).

S. M. Hatfield and M. Sitkovsky, “Oxygenation to Improve Cancer Vaccines, Adoptive Cell Transfer and Blockade of Immunological Negative Regulators,” Oncoimmunology 4, no. 12 (2015): e1052934.

M. L. Margolis et al., “Racial Differences Pertaining to a Belief about Lung Cancer Surgery: Results of a Multicenter Survey,” Annals of Internal Medicine 139, no. 7 (2003): 558–563.

A. James, C. M. Daley, and K. A. Greiner, “‘Cutting’ on Cancer: Attitudes about Cancer Spread and Surgery among Primary Care Patients in the USA,” Social Science and Medicine 73, no. 11 (2011): 1669–1673.

H. V. Ratajczak, R. B. Sothern, and W. J. M. Hrushesky, “Estrous Influence on Surgical Cure of a Mouse Breast Cancer,” Journal of Experimental Medicine 168 (1988): 73–83.

R. A. Badwe et al., “Timing of Surgery During Menstrual Cycle and Survival of Premenopausal Women with Operable Breast Cancer,” The Lancet 337 (1991): 1261–1264; R. Sainsbury et al., “Timing of Surgery for Breast Cancer and Menstrual Cycle,” The Lancet 338 (1991): 391–392.